View stunning SlideShares in full-screen with the new iOS app!Introducing SlideShare for AndroidExplore all your favorite topics in the SlideShare appGet the SlideShare app to Save for Later — even offline
View stunning SlideShares in full-screen with the new Android app!View stunning SlideShares in full-screen with the new iOS app!
Comparative study of Cefpodoxime
and to study the market potential for
’s product portfolio.
Ranbaxy & Daiichi
Merger rank top 20 global
June 2008, with pharmaceutical
Daiichi Sankyo companies.
1961 and went No. 1 Indian Pharma
public in 1973 Company
Started by Ranbir Global consolidated
Singh and Gurbax sales –US $ 1519 Mn
Singh 1937 (2009)
(Cefpodoxime proxetil) is an orally
administered, extended spectrum, semi-
syntheticantibiotic of the cephalosporin class.
Cefpodoxime is active against a wide spectrum of Gram-positive and Gram-
negative bacteria. Cefpodoxime is stable in the presence of beta-lactamase
enzymes. As a result, many organisms resistant to penicillins and
cephalosporins, due to their production of beta-lactamase, may be susceptible
FOR PRODUCT PORTFOLIO
◦ CEPODEM-XP (Cefpodoxime + Clavulanic Acid)
◦ CEROXIM (Cefuroxime)
◦ CEROXIM-XP (Cefuroxime + Clavulanic Acid)
◦ RACIPER (Esomeprazole)
◦ RICONIA (Multivitamin)
◦ ALTRAFLAM (Aceclofenac)
◦ SYNASMA (Doxofylline)
◦ & GEMBAX (Gemifloxacin)
1 To know the market share of the
Ranbaxy’s Products in Ranbaxy
2 To know about the current products that
are giving a tough competition to
3 To know about the new competitors that
have entered into the market and are
trying to capture some of it’s share.
Type of Research: Exploratory research
Sample unit: Retailer
Sample extent: South Delhi
Sampling technique: Convenient sampling
Sample size: 100 Retailers
Data collection methods:
Primary methods: (a)Face to face interactions (b) Questionnaire
Secondary methods: Company manuals ,Journals ,Magazines & Internet
Microsoft Excel has been used for the statistical analysis.
Sometime respondents refuse to cooperate and it may possible that they
give biased and dishonest answers.